Advertisement

POZ July/August 2026

POZ July/August 2026

In every issue of POZ, you’ll find the latest health news, personal stories and much more.

Also Available On:

ISSUU

Features

Kyle Clifford

Building on amfAR’s Legacy of Action

Kyle Clifford, the nonprofit’s first openly HIV-positive CEO, urges people living with the virus to stay committed to the fight.

Diverse People Hang Out Pub Friendship

35 Years of Dining Out For Life

The nationwide fundraiser continues to provide a place at the table for people living with HIV.

POZ 2026 HIV Drug Chart

2026 HIV Drug Chart

This quick-reference chart compares antiretroviral (ARV) options for the treatment of HIV, including adult dosing and dietary restrictions.

Editor’s Letter

Chemistry laboratory equipment with laboratory flask and beaker. Atom icon, modern chemistry and molecular force. Laboratory equipment with atomic nucleus

Don’t Give Up

I have to juggle my joy about potential cures with the realities about the widespread implementation of a practical cure for HIV.

POZ Q&A

Sean Strub (center) at an ACT UP protest

The Wizard of POZ

Long-term survivor Sean Strub reflects on his time as mayor of Milford, Pennsylvania, and his HIV activism.

POZ Planet

open book grass blue sky

Informed and Inspired Summer Reading

Here’s a roundup of recent nonfiction books on HIV and AIDS.

Us dollar in laboratory tube flask beaker

Investing in HIV Treatments Fuels the U.S. Economy

Scientific breakthroughs against the virus extended lifespans and generated trillions of dollars.

mortor and pestle and AIDS Ribbon icon

Rx for Change to Boost PrEP Access

A new national coalition launches a pilot program in two states.

Bay Area Reporter 1982 gay men’s pneumonia.

Everyday – July/August 2026

These dates represent milestones in the HIV epidemic. Visit poz.com/aidsiseveryday to learn more about the history of HIV and AIDS.

Voices

African and caucasian women reaching out their hands to each other

Hard to Reach

Below is an edited excerpt of an AIDS United blog post titled “In the HIV Field, We Call Them ‘Hard to Reach.’ Maybe the Issue Is Us.”

Amanda Cary

We’re Losing

In an opinion piece titled “The Providers We’re Losing: Remembering Amanda Cary,” HIV advocate eulogizes his friend.

Spotlight

GMHC hosted the 41st annual AIDS Walk New York in Central Park

AIDS WALK NY 2026

This year’s 41st annual AIDS Walk New York proved that people will continue to fight for those affected by HIV and AIDS.

basics

Female doctor discusses medication with patient

Switching HIV Treatment

Newer antiretroviral regimens are more effective, better tolerated and easier to use.

research notes

Young man with a PrEP pill

Prevention: On-Demand PrEP

The PREVENIR trial compared the use of once-daily and intermittent PrEP.

frican-American mother having fun with cute baby boy on the bed

Treatment: Early Treatment

Children who start antiretrovirals immediately after birth have a higher likelihood of controlling the virus after stopping treatment

HIV virus attacking cell. 3D reder.

Cure: CAR-T for HIV

A one-time infusion of CAR-T therapy led to delayed HIV rebound or sustained viral suppression after stopping antiretrovirals.

One bathroom scale on color background, top view

Concerns: Obesity in Kids

Obesity has been rising among adults and children with or without HIV.

Care & treatment

FDA

FDA Approves Idvynso Combination Pill

The Food and Drug Administration approved Merck’s once-daily single-tablet regimen containing doravirine and islatravir.

Customer satisfaction meter with different emotions.

New CDC Data on HIV Cases and Care Indicators

The updated numbers show that the United States is not on track to meet national goals for ending the HIV epidemic.

Toronto skyline with CN Tower at sunset.

Toronto Man Cured of HIV After Stem Cell Transplant

He has undetectable HIV-specific T-cell responses, suggesting there may be no remaining virus to trigger his immune system.

Time lapse concept - snail and clock

HIV Treatment Slows Accelerated Aging

People living with HIV are prone to developing comorbidities, such as cardiovascular disease, earlier than their HIV-negative peers.

Heroes

Princess Jauan Durbin

Centering Lived Experience

At only 27 years old, Princess Jauan Durbin already has a decade of advocacy experience under their belt.

Digital Edition

POZ July/August 2026 cover

POZ July/August 2026

Read the digital edition.

Advertisement

Hot topics


POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.